| Term | Count | % | | TREATMENT FAILURE | 5926 | 6.82% |
| DRUG INEFFECTIVE | 3315 | 3.81% |
| EYE IRRITATION | 2512 | 2.89% |
| FATIGUE | 2353 | 2.71% |
| INTRAOCULAR PRESSURE INCREASED | 1864 | 2.14% |
| HEADACHE | 1858 | 2.14% |
| EYE PAIN | 1803 | 2.07% |
| DEATH | 1691 | 1.94% |
| DYSPNOEA | 1677 | 1.93% |
| DIARRHOEA | 1662 | 1.91% |
| VISION BLURRED | 1660 | 1.91% |
| DIZZINESS | 1656 | 1.90% |
| OFF LABEL USE | 1636 | 1.88% |
| NAUSEA | 1607 | 1.85% |
| OCULAR HYPERAEMIA | 1517 | 1.74% |
| FALL | 1445 | 1.66% |
| CATARACT | 1383 | 1.59% |
| GLAUCOMA | 1380 | 1.59% |
| PAIN | 1317 | 1.51% |
| ASTHENIA | 1295 | 1.49% |
| HYPERSENSITIVITY | 1181 | 1.36% |
| RASH | 1062 | 1.22% |
| VISUAL IMPAIRMENT | 1052 | 1.21% |
| MALAISE | 1023 | 1.18% |
| PNEUMONIA | 1019 | 1.17% |
| WEIGHT DECREASED | 985 | 1.13% |
| PRURITUS | 981 | 1.13% |
| CONDITION AGGRAVATED | 973 | 1.12% |
| COUGH | 953 | 1.10% |
| PAIN IN EXTREMITY | 948 | 1.09% |
| ARTHRALGIA | 944 | 1.09% |
| VOMITING | 889 | 1.02% |
| HYPERTENSION | 857 | 0.99% |
| EYE PRURITUS | 822 | 0.95% |
| PRODUCT DOSE OMISSION ISSUE | 795 | 0.91% |
| DRUG HYPERSENSITIVITY | 770 | 0.89% |
| CONSTIPATION | 750 | 0.86% |
| DRY EYE | 745 | 0.86% |
| VISUAL ACUITY REDUCED | 738 | 0.85% |
| CONFUSIONAL STATE | 708 | 0.81% |
| PYREXIA | 708 | 0.81% |
| INSOMNIA | 701 | 0.81% |
| EYE DISORDER | 667 | 0.77% |
| DEPRESSION | 665 | 0.76% |
| DECREASED APPETITE | 664 | 0.76% |
| BACK PAIN | 646 | 0.74% |
| PRODUCT QUALITY ISSUE | 629 | 0.72% |
| CEREBROVASCULAR ACCIDENT | 618 | 0.71% |
| SOMNOLENCE | 610 | 0.70% |
| URINARY TRACT INFECTION | 609 | 0.70% |
| ACUTE KIDNEY INJURY | 602 | 0.69% |
| GAIT DISTURBANCE | 591 | 0.68% |
| ANAEMIA | 564 | 0.65% |
| INCORRECT DOSE ADMINISTERED | 563 | 0.65% |
| BLOOD PRESSURE INCREASED | 561 | 0.65% |
| ANXIETY | 546 | 0.63% |
| HYPOTENSION | 545 | 0.63% |
| ABDOMINAL DISCOMFORT | 540 | 0.62% |
| FEELING ABNORMAL | 538 | 0.62% |
| PALPITATIONS | 534 | 0.61% |
| CHEST PAIN | 533 | 0.61% |
| LACRIMATION INCREASED | 530 | 0.61% |
| ERYTHEMA | 519 | 0.60% |
| COVID-19 | 510 | 0.59% |
| PRODUCT USE IN UNAPPROVED INDICATION | 498 | 0.57% |
| PRODUCT USE ISSUE | 492 | 0.57% |
| PERIPHERAL SWELLING | 487 | 0.56% |
| BLINDNESS | 481 | 0.55% |
| MYALGIA | 481 | 0.55% |
| ARTHRITIS | 475 | 0.55% |
| ATRIAL FIBRILLATION | 470 | 0.54% |
| MUSCLE SPASMS | 464 | 0.53% |
| NASOPHARYNGITIS | 462 | 0.53% |
| DRUG INTOLERANCE | 461 | 0.53% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 451 | 0.52% |
| TREMOR | 449 | 0.52% |
| HAEMOGLOBIN DECREASED | 443 | 0.51% |
| RENAL FAILURE | 442 | 0.51% |
| OEDEMA PERIPHERAL | 434 | 0.50% |
| ABDOMINAL PAIN UPPER | 429 | 0.49% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 415 | 0.48% |
| ABDOMINAL PAIN | 410 | 0.47% |
| DEHYDRATION | 409 | 0.47% |
| WEIGHT INCREASED | 408 | 0.47% |
| ALOPECIA | 405 | 0.47% |
| BRONCHITIS | 396 | 0.46% |
| EYE SWELLING | 396 | 0.46% |
| MUSCULAR WEAKNESS | 393 | 0.45% |
| SYNCOPE | 382 | 0.44% |
| MEMORY IMPAIRMENT | 377 | 0.43% |
| DYSGEUSIA | 371 | 0.43% |
| MYOCARDIAL INFARCTION | 369 | 0.42% |
| FOREIGN BODY SENSATION IN EYES | 367 | 0.42% |
| BALANCE DISORDER | 365 | 0.42% |
| VERTIGO | 364 | 0.42% |
| BLOOD GLUCOSE INCREASED | 363 | 0.42% |
| HYPOAESTHESIA | 354 | 0.41% |
| ASTHMA | 353 | 0.41% |
| PARAESTHESIA | 349 | 0.40% |
| CARDIAC FAILURE CONGESTIVE | 342 | 0.39% |
| Total | 86952 | |